Search results for: 'Drug Discovery and Early Development Outsourcing Market'
- Did you mean
- drug discovery and earth development outsourcing market
- drug discovery and earn development outsourcing market
- Related search terms
- developments in the european smart thermostats market present strong opportunities for growth
- AND 6153=5227-- cSlQ
- drug 01 00 00 00
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
09 Oct 2025  |  Global  |  Technology Research
Research and Development Opportunities in Organoid Platforms for Cancer Applications
Emerging Trends and Technologies in Organoid-Enabled Cancer Modeling, Drug Discovery, Precision Medicine, and Therapeutic Screening
This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...
$4,950.00 -
13 Dec 2021  |  Global  |  Technology Research
Technology Enablers Facilitating Microbiome Adoption in Research and Development
Advancements in Analytical Methods and Digital Tools Fuel Growth Opportunities in Microbiome Research and Product Development
Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jun 2026  |  Global  |  Market Research
Top 5 Growth Opportunities in AI-Enabled Drug Discovery, 2026
Growing Precision Medicine Research is Driving Agile Partnerships with Newer OoC Technologies
As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...
$2,450.00 -
25 Apr 2022  |  North America  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Jun 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...
$950.00 -
13 Jul 2022  |  Global  |  Technology Research
Growth Opportunities for Digital Biomarkers in Drug Development
Transformational Growth for Clinical Trials via Enhancements to Patient Recruitment, Stratification, Monitoring, and Drug Response Comprehension
Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data on the effectiveness of the investigation of medical products contribute to their low success rate. Digital bio...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Jan 2024  |  Global  |  Market Research
Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024
Tech-enabled Partnerships Propelling Drug Discovery and Development in Precision Oncology, Rare Diseases, and Obesity
In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 Jul 2026  |  Global  |  Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
Expansion in Sterile Fill-Finish and ADC-Payload-Linkers Capabilities Will Meet Critical Demand for High-Value Injectables
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...
$2,450.00 -
23 Jun 2021  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00
Special Price $3,712.50 save 25 %